title: Primary amebic meningoencephalitis.
abstract: We report an 8 month-old infant with primary amebic meningoencephalitis (PAME) due to Naegleria fowleri. The child was treated with amphotericin B, chloramphenicol and rifampicin for 3 weeks. PAME is an almost universally fatal condition with very few survivors till date. Our patient was one of the rare survivors who recovered after treatment and was discharged without any residual neurological deficit.
authors.affiliation: Department of Pediatrics, MLN Medical College, University of Allahabad, Allahabad, UP, India. drruchi.rai@indiatimes.com
authors.forename: Ruchi
authors.initials: R
authors.lastname: Rai
authors.forename: D K
authors.initials: DK
authors.lastname: Singh
authors.forename: A K
authors.initials: AK
authors.lastname: Srivastava
authors.forename: Anudita
authors.initials: A
authors.lastname: Bhargava
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008297:Male; D008590:Meningoencephalitis / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology; D016848:Naegleria fowleri / Q000302:isolation & purification*; D011500:Protein Synthesis Inhibitors / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D011500:Protein Synthesis Inhibitors; D002701:Chloramphenicol; D000666:Amphotericin B; D012293:Rifampin